What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND study. (2019)
Attributed to:
MICA: MRC APBI STratification and Extreme Response Mechanism IN Diabetes - MASTERMIND
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12916-019-1307-8
PubMed Identifier: 30979373
Publication URI: http://europepmc.org/abstract/MED/30979373
Type: Journal Article/Review
Volume: 17
Parent Publication: BMC medicine
Issue: 1
ISSN: 1741-7015